香港股市 將在 8 小時 30 分鐘 開市

Laboratory Corporation of America Holdings (LH)

NYSE - Nasdaq 即時價格。貨幣為 USD。
加入追蹤清單
205.96+0.23 (+0.11%)
市場開市。 截至 01:00PM EDT。

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336 229 1127
https://www.labcorp.com

版塊Healthcare
行業Diagnostics & Research
全職員工56,950

高階主管

名稱頭銜支付行使價出生年份
Mr. Adam H. SchechterPresident, CEO & Chairman4.66M1965
Mr. Glenn A. EisenbergCFO & Executive VP1.87M1961
Mr. Mark S. SchroederExecutive VP, President of Diagnostics Laboratories & COO1.43M129.25k1961
Dr. Brian J. Caveney J.D., M.D., M.P.H.EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer1.3M1974
Ms. Anita Z. GrahamExecutive VP & Chief Human Resources Officer1.35M1971
Mr. Peter J. WilkinsonSenior VP & Chief Accounting Officer1972
Mr. Lance V. BerberianExecutive VP and Chief Information & Technology Officer876.62k1963
Christin O'DonnellVice President of Investor Relations
Ms. Sandra D. van der VaartExecutive VP, Chief Legal Officer, Chief Compliance Officer & Corporate Secretary1960
Ms. Amy B. SummyExecutive VP & Chief Marketing Officer1967
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

公司管治

截至 2024年4月1日 止,Laboratory Corporation of America Holdings 的 ISS 管治質素評分為 2。 Pillar 分數正在審核中:5;董事會:7;股東權利:1;現金賠償:2。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。